#AACR24 is almost here! Plan your conference with our free AACR planner bit.ly/3vBd8of (no sign-in needed). See you in San Diego! #oncology #hematology #strategy #LucidQuest #competitiveintelligence #cancerresearch #conferenceplanning @AACR

From Scarcity to Sufficiency: Understanding and Resolving the Cancer Drug Shortage in the United States - LucidQuest Ventures lqventures.com/from-scarcity-… #lucidquest

Gene&Cell Therapy >> Acepodia's off-the-shelf cell therapies get another $100M for oncology trials: California and Taipei biotech Acepodia has lined up another six-figure funding round to take its off-the-shelf cell… #lucidquest #genetherapy #celltherapy dlvr.it/SqFNww

Gene&Cell Therapy >> Biogen cuts PhIII Parkinson’s program over ‘long timeline’ : Biogen is calling it quits on a late-stage Parkinson’s trial as part of an ongoing R&D reorganization. The Cambridge, MA-based… #lucidquest #genetherapy #celltherapy dlvr.it/SqBMhP

Gene&Cell Therapy >> Exclusive: Affini-T taps Sanofi alum to lead hunt for partnerships; Alkermes locks in CEO for oncology spinout: Thaminda Ramanayake Affini-T is looking for a partner as its KRAS-targeting T… #lucidquest #genetherapy #celltherapy dlvr.it/Sq2LKT

Gene&Cell Therapy >> Precision BioSciences to meet with FDA after touting allogeneic CAR-T win: Precision BioSciences is now touting new data from a Phase I/II trial, saying that it has identified a dosing regimen… #lucidquest #genetherapy #celltherapy dlvr.it/Spx25z

Gene&Cell Therapy >> Seres receives $125M payment from Nestlé; French biotech teases early-stage eye disease data: Seres Therapeutics, a microbiome-focused biotech, has been handed a $125 million milestone payment… #lucidquest #genetherapy #celltherapy dlvr.it/Spx23H

Gene&Cell Therapy >> RA Capital-backed non-viral gene therapy startup Summation Bio to shut down: As a string of new gene therapy startups aims to create treatments without the go-to shuttling method of an AAV virus,… #lucidquest #genetherapy #celltherapy dlvr.it/Spw1wt

Gene&Cell Therapy >> With cash running low, cell therapy company Idogen looks to sell off platform before liquidation: Small cell therapy company Idogen will have to liquidate the company if another solution isn’t… #lucidquest #genetherapy #celltherapy dlvr.it/Spsl4x

Learn about what BioPharma CVC invest in in 2023! (link in comments) 1. 📊 LucidQuest's 2023 report analyses the CVC portfolios of 19 Biopharma companies and Google, highlighting key investment trends. 📈 #lucidquest #venturecapital 2. 🎯 Google Venture…lnkd.in/eAdxHSHn

Gene&Cell Therapy >> BenchSci raises $70M Series D for drug discovery software; Zentalis touts PhIb ovarian cancer data: Canada’s BenchSci has raised $70 million in a Series D round designed to scale its AI drug… #lucidquest #genetherapy #celltherapy dlvr.it/SpgdVj

Gene&Cell Therapy >> Artiva boasts early NK cell therapy results, giving lifeline to partner Affimed: Artiva Biotherapeutics reported early data on its off-the-shelf NK cell therapy in combination with rituximab,… #lucidquest #genetherapy #celltherapy dlvr.it/SpgdVc